Study Reaffirms Safety of Hepatitis C Meds in Liver Cancer Patients
By American Heart Association News
TUESDAY, Feb. 12, 2019 (HealthDay News) — It’s safe to use antiviral drugs to treat hepatitis C in liver cancer survivors, a new study reports. The findings contradict previous research suggesting that antiviral drugs might increase these patients’ risk of liver cancer recurrence. That prior research involved a single-center study […]
The post Study Reaffirms Safety of Hepatitis C Meds in Liver Cancer Patients appeared first on News on Heart.org.